Biotech Co. Insiders Sued In Del. Over $200M PIPE Deal Gain
Investors of clinical-stage pharmaceutical company Taysha Gene Therapies Inc. sued the company's directors and officers in Delaware Chancery Court to recover more than $200 million in damages on behalf of the...To view the full article, register now.
Already a subscriber? Click here to view full article